Form 4: First Tracks Biotherapeutics Executive Receives Stock Grant
Insider Transaction (Form 4)
Benjamin Stone, Chief Business Officer of First Tracks Biotherapeutics, Inc., received 60,492 shares of common stock on August 2, 2026.
Summary
- Grant/award: acquired 60,492 Performance Stock Units on August 2, 2026; holds 77,159 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Benjamin Stone — Officer (Chief Business Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-02 | Grant/award | Performance Stock Units | 60,492 | — | — | 77,159 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-02 | Grant/award (60,492 shares) |
Keywords
insider transaction, Form 4, TRAX, First Tracks Biotherapeutics, Inc., neutral, Benjamin Stone
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.